Patents by Inventor Bayer Pharma Aktiengesellschaft

Bayer Pharma Aktiengesellschaft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
    Publication number: 20140128424
    Abstract: The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
    Type: Application
    Filed: March 7, 2013
    Publication date: May 8, 2014
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventor: BAYER PHARMA AKTIENGESELLSCHAFT
  • Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
    Publication number: 20130309302
    Abstract: The present invention relates to manufacturing processes for the preparation of a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil and optionally at least one diuretic characterized in that nifedipine is released in the body in a controlled (modified) manner and the candesartan cilexetil is released rapidly (immediate release (IR)) and optionally the diuretic is released rapidly (immediate release (IR)) and the pharmaceutical dosage forms obtainable by these processes.
    Type: Application
    Filed: May 7, 2013
    Publication date: November 21, 2013
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventor: Bayer Pharma Aktiengesellschaft